Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Wildemann

Showing results (141-150 of 204) with videos related to

Pageof 21
Sort By:
Journal of Neurology|September 7, 2023
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term managementTania Kümpfel, Katrin Giglhuber, Orhan Aktas, et al.
Brain : a Journal of Neurology|December 1, 2021
Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunityMarie Liebmann, Lisanne Korn, Claudia Janoschka, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 6, 2026
Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world dataFelix Fischbach, Johanna Richter, Miriam Korporal-Kuhnke, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 2022
Association of obesity with disease outcome in multiple sclerosisIsabel Lutfullin, Maria Eveslage, Stefan Bittner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 7, 2023
Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapiesCarolin Schwake, Thivya Pakeerathan, Ingo Kleiter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 10, 2021
Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive PatientsIlya Ayzenberg, Daniel Richter, Eugenia Henke, et al.
Der Nervenarzt|July 13, 2019
[Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]Stefan Bittner, Sinah Engel, Christoph Lange, et al.
Autoimmunity Reviews|February 13, 2025
Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?Franz F Konen, Ulrich Wurster, Philipp Schwenkenbecher, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2020
Genetic determinants of the humoral immune response in MSChristiane Gasperi, Till F M Andlauer, Ana Keating, et al.
Journal of Neuroinflammation|September 5, 2020
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patientsSven Jarius, Hannah Pellkofer, Nadja Siebert, et al.
Pageof 21

Showing results (141-150 of 204) with videos related to

Sort By:
Pageof 21
Journal of Neurology|September 7, 2023
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term managementTania Kümpfel, Katrin Giglhuber, Orhan Aktas, et al.
Brain : a Journal of Neurology|December 1, 2021
Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunityMarie Liebmann, Lisanne Korn, Claudia Janoschka, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 6, 2026
Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world dataFelix Fischbach, Johanna Richter, Miriam Korporal-Kuhnke, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 2022
Association of obesity with disease outcome in multiple sclerosisIsabel Lutfullin, Maria Eveslage, Stefan Bittner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 7, 2023
Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapiesCarolin Schwake, Thivya Pakeerathan, Ingo Kleiter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 10, 2021
Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive PatientsIlya Ayzenberg, Daniel Richter, Eugenia Henke, et al.
Der Nervenarzt|July 13, 2019
[Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]Stefan Bittner, Sinah Engel, Christoph Lange, et al.
Autoimmunity Reviews|February 13, 2025
Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?Franz F Konen, Ulrich Wurster, Philipp Schwenkenbecher, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2020
Genetic determinants of the humoral immune response in MSChristiane Gasperi, Till F M Andlauer, Ana Keating, et al.
Journal of Neuroinflammation|September 5, 2020
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patientsSven Jarius, Hannah Pellkofer, Nadja Siebert, et al.
Pageof 21